Many diseases such as diabetes, hypertrophic cardiomyopathy, hypothyroidism and heart failure involve alterations in the contractile and regulatory proteins of the myocardium. Changes in protein isoforms due to disease or mutation could impair cardiac function during normal activation of the heart or during strenuous activity. The long term objective of our research is to understand the complex molecular interactions between actomyosin cross-bridges (CBs) and thin filament (TF) proteins that regulate cardiac contractile function. In skeletal muscle the CB transition rates that control force development and fiber shortening have been studied using caged compound techniques and by varying substrate and hydrolysis product conditions. The CB processes that are rate limiting for force development and shortening in myocardium are less well understood than in skeletal muscle, and may be different. Additionally, the regulation of cardiac contractions appears to be dependent on a complex interaction between TF proteins and CBs. Using transient kinetics of isolated proteins in solution and glycerinated cardiac muscle we will study the rates of CB steps that govern actomyosin interaction and the influence of TnC Ca/2+ binding kinetics, comparing these with skeletal muscle. To test this we will independently alter the kinetics of TF activation and CB transition rates to determine how each affects steady state force and stiffness, the rate of force development and the velocity of shortening. We will also study the influence of protein phosphorylation and contractile filament lattice spacing on these measurements. The information gained from these studies will be used to modify and extend existing models of CB chemomechanical transduction and the regulation of CBs by TF proteins. These models will be useful in describing the important differences between cardiac and skeletal muscle in the control of force and shortening and the changes that occur in cardiac myopathies.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL061683-03
Application #
6330186
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Liang, Isabella Y
Project Start
1998-12-15
Project End
2002-11-30
Budget Start
2000-12-01
Budget End
2001-11-30
Support Year
3
Fiscal Year
2001
Total Cost
$254,902
Indirect Cost
Name
University of Washington
Department
Biomedical Engineering
Type
Schools of Engineering
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Teichman, Sam L; Thomson, Kassandra S; Regnier, Michael (2017) Cardiac Myosin Activation with Gene Therapy Produces Sustained Inotropic Effects and May Treat Heart Failure with Reduced Ejection Fraction. Handb Exp Pharmacol 243:447-464
Thomson, Kassandra S; Odom, Guy L; Murry, Charles E et al. (2016) Translation of Cardiac Myosin Activation with 2-deoxy-ATP to Treat Heart Failure via an Experimental Ribonucleotide Reductase-Based Gene Therapy. JACC Basic Transl Sci 1:666-679
Kreutziger, Kareen L; Piroddi, Nicoletta; McMichael, Jonathan T et al. (2011) Calcium binding kinetics of troponin C strongly modulate cooperative activation and tension kinetics in cardiac muscle. J Mol Cell Cardiol 50:165-74
Rodriguez, Anthony G; Han, Sangyoon J; Regnier, Michael et al. (2011) Substrate stiffness increases twitch power of neonatal cardiomyocytes in correlation with changes in myofibril structure and intracellular calcium. Biophys J 101:2455-64
Moreno-Gonzalez, Alicia; Korte, F Steven; Dai, Jin et al. (2009) Cell therapy enhances function of remote non-infarcted myocardium. J Mol Cell Cardiol 47:603-13
Kreutziger, Kareen L; Piroddi, Nicoletta; Scellini, Beatrice et al. (2008) Thin filament Ca2+ binding properties and regulatory unit interactions alter kinetics of tension development and relaxation in rabbit skeletal muscle. J Physiol 586:3683-700
Kreutziger, Kareen L; Gillis, Todd E; Davis, Jonathan P et al. (2007) Influence of enhanced troponin C Ca2+-binding affinity on cooperative thin filament activation in rabbit skeletal muscle. J Physiol 583:337-50
Shaffer, Justin F; Razumova, Maria V; Tu, An-Yue et al. (2007) Myosin S2 is not required for effects of myosin binding protein-C on motility. FEBS Lett 581:1501-4
Moreno-Gonzalez, Alicia; Gillis, Todd E; Rivera, Anthony J et al. (2007) Thin-filament regulation of force redevelopment kinetics in rabbit skeletal muscle fibres. J Physiol 579:313-26
Martyn, D A; Smith, L; Kreutziger, K L et al. (2007) The effects of force inhibition by sodium vanadate on cross-bridge binding, force redevelopment, and Ca2+ activation in cardiac muscle. Biophys J 92:4379-90

Showing the most recent 10 out of 22 publications